Trial Profile
A study of the relationship between the HLA-DR beta 1 genotype and therapeutic response of abatacept (ABT) in patients with rheumatoid arthritis (RA)
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 22 Dec 2016
Price :
$35
*
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacogenomic; Therapeutic Use
- 03 Oct 2016 Status changed from not yet recruiting to recruiting.
- 08 Dec 2015 New trial record